Myron Kaplan insider trades: CorMedix (CRMD) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Myron reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | CRMD | ↑ Buy | 25,000 | $11.02 | $276K | Direct | Oct 27, 2025 (4d) |
| May 18, 2023 | CRMD | ↑ Buy | 6,000 | $4.54 | $27K | Direct | May 19, 2023 (1d) |
| May 17, 2022 | CRMD | ↑ Buy | 5,000 | $3.78 | $19K | Direct | May 18, 2022 (1d) |
| Nov 16, 2021 | CRMD | ↑ Buy | 10,000 | $5.14 | $51K | Direct | Nov 19, 2021 (3d) |
| May 17, 2021 | CRMD | ↑ Buy | 15,000 | $6.03 | $90K | Direct | May 19, 2021 (2d) |
| Sep 2, 2020 | CRMD | ↑ Buy | 15,300 | $4.27 | $65K | Direct | Sep 4, 2020 (2d) |
| Aug 13, 2020 | CRMD | ↑ Buy | 15,000 | $4.08 | $61K | Direct | Aug 17, 2020 (4d) |
| May 15, 2020 | CRMD | ↑ Buy | 10,000 | $3.85 | $39K | Direct | May 18, 2020 (3d) |
| Sep 30, 2019 | CRMD | ↑ Buy | 5,000 | $6.81 | $34K | Direct | Oct 1, 2019 (1d) |
| Aug 16, 2019 | CRMD | ↑ Buy | 6,000 | $8.06 | $48K | Direct | Aug 16, 2019 (0d) |
| Mar 22, 2019 | CRMD | ↑ Buy | 20,000 | $1.65 | $33K | Direct | Mar 22, 2019 (0d) |
| Dec 14, 2018 | CRMD | ↑ Buy | 50,000 | $1.47 | $73K | Direct | Dec 17, 2018 (3d) |
| Nov 23, 2018 | CRMD | ↑ Buy | 50,000 | $1.30 | $65K | Direct | Nov 27, 2018 (4d) |
| Dec 12, 2017 | CRMD | ↑ Buy | 104,166 | $0.48 | $50K | Direct | Dec 14, 2017 (2d) |
| Aug 17, 2017 | CRMD | ↑ Buy | 80,000 | $0.40 | $32K | Direct | Aug 21, 2017 (4d) |
| Aug 14, 2017 | CRMD | ↑ Buy | 50,000 | $0.35 | $17K | Direct | Aug 16, 2017 (2d) |
| May 15, 2017 | CRMD | ↑ Buy | 30,000 | $0.49 | $15K | Direct | May 17, 2017 (2d) |
| Aug 19, 2016 | CRMD | ↑ Buy | 20,000 | $1.72 | $34K | Direct | Aug 23, 2016 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRMD insiders
Open-market trades in the last 12 months
About Myron Kaplan's insider trades
Myron Kaplan is a director at CorMedix (CRMD). Since Aug 19, 2016, Myron has reported 18 open-market purchases worth $1.0M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (13 filings), option exercises (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.